Trayambak Dutta

Ahmedabad, UP 382481, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

A Multi-State, Cross-Sectional Retrospective Study on Knowledge, Attitude and Practice of Rabies Post-Exposure Prophylaxis Including Rabies Monoclonal Antibody Among Physicians Across India.

A Multi-State, Cross-Sectional Retrospective Study on Knowledge, Attitude and Practice of Rabies Post-Exposure Prophylaxis Including Rabies Monoclonal Antibody Among Physicians Across India.

Journal: Vaccines

Published: June 17, 2026

Life Course Vaccination Continuum (LCVAC): An Expert Consensus on Life Course Vaccination in India.

Life Course Vaccination Continuum (LCVAC): An Expert Consensus on Life Course Vaccination in India.

Journal: Cureus

Published: May 21, 2026

Real-World Safety Profile of an Indian Trivalent Influenza Vaccine: Results From a Multi-centre Post-marketing Surveillance Study.

Real-World Safety Profile of an Indian Trivalent Influenza Vaccine: Results From a Multi-centre Post-marketing Surveillance Study.

Journal: Cureus

Published: May 06, 2026

Safety profile of India's influenza vaccine in a large-scale corporate vaccination drive.

Safety profile of India's influenza vaccine in a large-scale corporate vaccination drive.

Journal: Human vaccines & immunotherapeutics

Published: February 03, 2026

Safety and Tolerance of a Novel MMR (Measles, Mumps, and Rubella) Vaccine in Indian Children: A Real-World Evidence Study.

Safety and Tolerance of a Novel MMR (Measles, Mumps, and Rubella) Vaccine in Indian Children: A Real-World Evidence Study.

Journal: Cureus

Published: December 19, 2025

In-Use Stability and Functional Efficacy of a Monoclonal Antibody Cocktail (TwinRab™) for Rabies Post-exposure Prophylaxis.

In-Use Stability and Functional Efficacy of a Monoclonal Antibody Cocktail (TwinRab™) for Rabies Post-exposure Prophylaxis.

Journal: Cureus

Published: November 28, 2025

An active post-marketing surveillance study to evaluate the safety and immunogenicity of Zyvac TCV in healthy participants.

An active post-marketing surveillance study to evaluate the safety and immunogenicity of Zyvac TCV in healthy participants.

Journal: Human vaccines & immunotherapeutics

Published: August 26, 2025

Consensus to Conquer Challenges in Influenza Immunization in Pulmonology Practice in India: Proceedings of the Congregation on Influenza Vaccination in Chronic Lung Diseases (CIRCLE) Expert Committee Meet.

Consensus to Conquer Challenges in Influenza Immunization in Pulmonology Practice in India: Proceedings of the Congregation on Influenza Vaccination in Chronic Lung Diseases (CIRCLE) Expert Committee Meet.

Journal: Cureus

Published: July 31, 2025

Immunogenicity and Safety Results of a Randomized, Three-Arm, Phase IV Clinical Trial of Concomitant Administration of Typhoid Vi Conjugate Vaccine with Measles and Rubella Vaccine in Healthy Infants.

Immunogenicity and Safety Results of a Randomized, Three-Arm, Phase IV Clinical Trial of Concomitant Administration of Typhoid Vi Conjugate Vaccine with Measles and Rubella Vaccine in Healthy Infants.

Journal: Viruses

Published: July 18, 2025

A prospective, randomized, parallel, active controlled, phase III Indian study of immunogenicity and safety of two inactivated influenza vaccines - Vaxiflu-4 and Fluarix tetra in children aged 6 months to 35 months.

A prospective, randomized, parallel, active controlled, phase III Indian study of immunogenicity and safety of two inactivated influenza vaccines - Vaxiflu-4 and Fluarix tetra in children aged 6 months to 35 months.

Journal: Human vaccines & immunotherapeutics

Published: October 24, 2024

Assessing the Safety of a Novel Monoclonal Antibody Cocktail for Postexposure Prophylaxis in Category III Animal Exposures.

Assessing the Safety of a Novel Monoclonal Antibody Cocktail for Postexposure Prophylaxis in Category III Animal Exposures.

Journal: International journal of applied & basic medical research

Published: June 13, 2024

Safety Evaluation of the Novel Cocktail of Monoclonal Antibodies for Postexposure Prophylaxis in Category III Animal Exposures.

Safety Evaluation of the Novel Cocktail of Monoclonal Antibodies for Postexposure Prophylaxis in Category III Animal Exposures.

Journal: Journal of global infectious diseases

Published: March 22, 2024

Showing 1-12 of 17

Last Updated: 09/26/2026